Biotech News ButlerBiotech News ButlerBETA
TrendingFeedbackLog In
Free BETA

Your Daily Biotech News Reading List

Define topics in plain English, and receive a short daily digest of matching headlines.

Compact Format

One clustered email per day from trusted biotech sources.

AI-Curated

Define topics in natural language; AI matches headlines.

Learns From You

Rate headlines to improve future recommendations.

Join the test list (free)
Enter your email to receive your personalized daily digest

Email will only be used to receive verification link and digest letters.
Personal hobby project. Service may pause or change anytime.

Trending Now in Biotech

Stories being covered by multiple trusted sources right now. Share any cluster with colleagues.

Aldeyra dry eye drug rejected again
Aldeyra dry eye drug gets third rejection from FDA, triggering stock slide— Endpoints NewsAldeyra collects third CRL for reproxalap in dry eye disease— BioWorld (Clarivate)
Federal judge blocks RFK vaccine overhaul
Federal court blocks RFK Jr.’s moves to upend US vaccine policy— BioPharma DiveFREEKennedy’s Vaccine Policy Overhaul Stymied by Federal Judge— BioSpaceFREE
Rhythm Imcivree fails Phase 3 obesity trial
Rhythm’s Imcivree fails Phase 3 rare form obesity trial— Endpoints NewsRhythm’s Imcivree Fails Late-Stage Weight Loss Trial in Rare Obesities— BioSpaceFREE
BioMarin pauses Voxzogo trials on safety signal
BioMarin halts Voxzogo trials due to safety signal— pharmaphorumFREEBioMarin halts Phase 2 Voxzogo dosing in certain patients over safety concern— Endpoints News
CytomX masked ADC posts positive CRC data
CytomX surges on positive data for ‘masked’ ADC in colorectal cancer— BioPharma DiveFREECytomx soars as early colorectal cancer data beat expectations— BioWorld (Clarivate)
Show all trending news

Updated every few hours. Subscribe to get personalized digests delivered to your inbox.